Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07124533 · ClinicalTrials.gov registry record · Phase 3

Effectiveness of Toothpaste Tablets on Plaque, Gingival Health and Caries Experiences

A Phase 3 study, sponsored by Loma Linda University.

Not yet
Registry status
Phase 3
Development phase
50
Enrollment target

NCT07124533 is a Phase 3 study that has not yet begun recruiting, run by Loma Linda University. The registered enrollment target is 50 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07124533, a Phase 3 study, has not yet begun recruiting, sponsored by Loma Linda University.

NOT YET RECRUITING
Registry status
Phase 3
Development phase
50 participants
Enrollment target

Study Summary

Objectives: To evaluate the effectiveness of toothpaste tablets when compared to conventional dentifrices in removing plaque. Methods: 50 participants are randomized into two groups: Denttabs toothpaste tablets (T) and Colgate's Cavity Protection toothpaste (P). Both groups utilize their assigned dentifrice for 6 weeks. A pre and post-assessment measures the Gingival Index (GI) and Plaque Index (PI) and Decayed, Missing and Filled Teeth (DMFT). A questionnaire on the use of the product is distributed at the end of the study.

Interventions

  • DRUG Toothpaste Tablet
  • DRUG Conventional Toothpaste

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2026-12
Est. Completion 2026-12
Phase Phase 3

Sponsor

Loma Linda University

237 total trials

What the Registry Record Tells You About NCT07124533

The ClinicalTrials.gov registry entry for NCT07124533 describes a study currently listed as not yet recruiting, categorized as Phase 3. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Toothpaste Tablet is the first listed.

NCT07124533 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07124533 about?

NCT07124533 is a clinical study titled "Effectiveness of Toothpaste Tablets on Plaque, Gingival Health and Caries Experiences". Objectives: To evaluate the effectiveness of toothpaste tablets when compared to conventional dentifrices in removing plaque. Methods: 50 participants are randomized into two groups: Denttabs toothpaste tablets (T) and Colgate's Cavity Protection toothpaste (P). Both groups utilize their assigned d...

What is the current status of trial NCT07124533?

This trial is currently not yet recruiting. It is a Phase 3 study. The enrollment target is 50 participants. The study started on 2026-12. Estimated completion is 2026-12.

What interventions are being tested in trial NCT07124533?

The interventions under investigation include: Toothpaste Tablet (DRUG), Conventional Toothpaste (DRUG).

Who is sponsoring clinical trial NCT07124533?

This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.